BlackRock Health Sciences Term Trust Files Proxy Statement

Ticker: BMEZ · Form: DEFA14A · Filed: May 31, 2024 · CIK: 1785971

Blackrock Health Sciences Term Trust DEFA14A Filing Summary
FieldDetail
CompanyBlackrock Health Sciences Term Trust (BMEZ)
Form TypeDEFA14A
Filed DateMay 31, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$1.3B, $200M, $3.6B, $3.2B, $2.4
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, sec-filing, governance

TL;DR

BlackRock Health Sciences Term Trust filed its proxy statement, no fee required.

AI Summary

BlackRock Health Sciences Term Trust filed a Definitive Proxy Statement (DEFA14A) on May 31, 2024. This filing is related to the company's proxy materials and does not involve a fee, as indicated by the 'No fee required' notation. The document is a definitive additional material, suggesting it supplements previous filings.

Why It Matters

This filing provides shareholders with important information regarding voting matters and corporate governance for BlackRock Health Sciences Term Trust.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not indicate any unusual financial or operational risks.

Key Players & Entities

  • BlackRock Health Sciences Term Trust (company) — Registrant
  • 0001193125-24-151962 (filing_id) — Accession Number
  • 20240531 (date) — Filing Date
  • 811-23466 (sec_file_number) — SEC File Number

FAQ

What type of filing is this DEFA14A for BlackRock Health Sciences Term Trust?

This filing is a Definitive Proxy Statement (DEFA14A) filed by BlackRock Health Sciences Term Trust.

When was this DEFA14A filed?

The filing date for this DEFA14A was May 31, 2024.

Is there a filing fee associated with this document?

No, the filing indicates 'No fee required'.

What is the SEC file number for BlackRock Health Sciences Term Trust?

The SEC file number for BlackRock Health Sciences Term Trust is 811-23466.

What is the business address of BlackRock Health Sciences Term Trust?

The business address is 100 Bellevue Parkway, Wilmington, DE 19809.

Filing Stats: 4,596 words · 18 min read · ~15 pages · Grade level 9.7 · Accepted 2024-05-31 17:24:22

Key Financial Figures

  • $1.3B — ed-end fund discounts. Weve bought back $1.3B in shares to date, resulting in more th
  • $200M — shares to date, resulting in more than $200M in gains to shareholders. Vote FOR Blac
  • $3.6B — onsistent value over time. We generated $3.6B in tangible gains in 2023 alone; we exp
  • $3.2B — 3 alone; we expect 2024 fund payouts of $3.2B to help you meet your financial goals.
  • $2.4 — Year* in 2023. Responsible for roughly $2.4 trillion in assets, Rick Rieder is a me
  • $2 million — , as well as fee waivers and a one-time $2 million management fee waiver for all muni CEFs
  • $1.3 billion — CEFs.2 Our Funds have also repurchased $1.3 billion in shares, generating significant gains
  • $1.41B — ning technically compliant. There is no $1.41B maqiC Saba claims that with a press of
  • $1.4 billion — ton BlackRock can # 2# magically create $1.4 billion in immediate value and that open- endin

Filing Documents

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. 1 follower PromotedblackRock and your Funds Board regularly act to address closed-end fund discounts. Weve bought back $1.3B in shares to date, resulting in more than $200M in gains to shareholders. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD.BlackRockBlackRock Closed-End Fund Investors:Were working to address CEF discounts and deliver long-term value.> Vote FOR BlackRock board nominees todayWe Act Regularly to Address CEF Discounts | BlackRock Q Learn moreblackrock.com 1 Defend Your Fund (by BlackRock)1 followerPromotedBlackRock and your Funds Board work to deliver consistent value over time. We generated $3.6B in tangible gains in 2023 alone; we expect 2024 fund payouts of $3.2B to help you meet your financial goals. Vote FOR BlackRocksâ BlackRockBlackRock Closed-End Fund Investors:Since 1988, our CEFs have delivered long-term value.> Vote FOR BlackRock board nominees todayWere Focused on Long-Term Value for CEF Investors | ( Learn more )BlackRock Defend Your Fund (by BlackRock)1 followerPromotedBlackRock and your Funds Board have taken numerous shareholder-friendly actions to narrow discounts, raise distributions, and deliver value for all shareholders. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD. #DefendYourFundBlackRockBlackRock Closed-End Fund Investors:Were working to deliver value for your financial future.> Vote FOR BlackRock board nominees todayOur Shareholder-Friendly CEF Actions | BlackRockblackrock.com Defend your fund Defend Your Fund (by BlackRock) 1 follower PromotedWe believe Saba is trying to take advantage of closed-end fund market conditions to make a quick profit at the expense of its fellow shareholders. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD.BlackRock Closed-End Fund Investors:A Farewell to Arbs Say No to Saba.> Vote FOR BlackRock board nominees todayA Farewell to Arbs: Say No To Sabas CEF Money Grab |( Learn more )BlackRockblackrock.com Defend Defend Your Fund (by BlackRock)fund\ 1 follower PromotedBlackRocks 35-year history managing closed-end funds stands in stark contrast to Saba, which has never launched a CEF and has forced dramatic change at the funds it has taken over. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD. Defend your fund Defend Your Fund (by BlackRock) 1 follower PromotedAttention BlackRock investors: keep your fundand your financial futurefrom falling into the wrong hands. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD. #DefendYourFundBlackRock Closed-End Fund Investors:Keep your fund out of the wrong hands.> Vote FOR BlackRock board nominees todayCEF Investors: Vote Now to Protect Your Financial Future | ( Learn more ) BlackRockblackrock.com Defend your fund Defend Your Fund (by BlackRock) 1 follower PromotedBlackRock and your Funds Board have consistently worked to improve performance and reduce discounts in recent years. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD. #DefendYourFundBlackRock Closed-End Fund Investors:Real actions have real impact.> Vote FOR BlackRock board nominees todayDelivering Performance, Value for All CEF Investors | (Learn more)BlackRockblackrock.com blackrock closed-end funds The future of your long-term investment depends on you Closed-end funds (CEFs) have been at the heart of BlackRock since our founding in 1988. At this years Annual Meetings in June, activist hedge fund, Saba Capital Management L.P. (Saba), is attempting to install its own handpicked nominees with little to no experience, and, in some instances, fire BlackRock as investment manager of one or more CEFs in which you are invested. We are asking all shareholders to make their voices heard. If Saba prevails, your investments may be at risk. Cast your vote The stakes could not be higher This proxy season, a well-known shareholder activist has launched proxy campaigns t

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.